Please assess the completion status of the following clinical trial:

Trial Title: Managing Insulin With a Voice AI

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with Type 2 Diabetes~* Patients clinically indicated to be taking daily long-acting insulin~* Patients currently taking long-acting insulin but necessitating active dose adjustments~Exclusion Criteria:~* Patients who do not speak English~* Patients who do not own a smart phone~* Patients who do not have stable wireless internet connection at home

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Voice Assistant Device (Type: EXPERIMENTAL): Subjects have their insulin titrated by a voice assistant device for 8 weeks. The Voice Assistant Device software algorithm is used to provide daily insulin dose and titration instructions.
- Control (Type: ACTIVE_COMPARATOR): Subjects have their insulin titrated via standard of care for 8 weeks. The Voice Assistant Device is limited to providing a daily reminder to take medication.

Based on this trial design, predict the completion outcome and termination type (if applicable).